About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of the Efficacy and Safety of MEDI4893

NCT02296320·49 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

MedImmune LLC

With

Innovative Medicines Initiative
Antibacterial Resistance Leadership Group
National Institute of Allergy and Infectious Diseases (NIAID)

Age

18–130

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Colonized with Staphylococcus aureus, expected to require prolonged intubation and mechanical ventilation, without any evidence of active pneumonia.

You may not be if

Staphylococcal disease at randomisation; lung injury score consistent with pneumonia; current lung disease; chronic tracheostomy patients; currently receiving systemic anti-staphylococcal antibiotics; moribund patients.

The record

StatusCompleted

PhasePhase 2

Taking part213

StartedOct 2014

UpdatedDec 23, 2019

Conditions

Staphylococcus Aureus Pneumonia

Where49

Research Site
Atlanta, Georgia, United States
Research Site
Detroit, Michigan, United States
Research Site
Arlon, Belgium

Clareo Health | Study of the Efficacy and Safety of MEDI4893